奈达铂与奥沙利铂热灌注治疗恶性腹腔积液的对比研究.docVIP

奈达铂与奥沙利铂热灌注治疗恶性腹腔积液的对比研究.doc

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
奈达铂与奥沙利铂热灌注治疗恶性腹腔积液的对比研究

精品论文 参考文献 奈达铂与奥沙利铂热灌注治疗恶性腹腔积液的对比研究 蒙艳凤 徐学新 杨国稳   【摘 要】 目的 探讨奈达铂与奥沙利铂热灌注治疗恶性腹腔积液的临床效果。方法 将92例恶性腹腔积液患者随机分为两组,每组46例。对照组给予奥沙利铂热灌注治疗,观察组给予奈达铂热灌注治疗,对比两组治疗效果、不良反应发生情况、生活质量评分情况。结果 观察组治疗总有效率为71.1%,明显高于对照组的45.7%,不良反应发生率为17.4%,低于对照组的45.7%,差异显著(p<0.05);治疗后,观察组生活质量评分明显高于对照组,差异显著(p<0.05)。结论 奈达铂热灌注治疗恶性腹腔积液的疗效确切,可有效控制积液水平,不良反应少,安全性高,对改善患者生活质量具有重要意义,优于奥沙利铂热灌注治疗。   【关键词】 恶性腹腔积液; 奈达铂; 奥沙利铂; 热灌注   Comparative Research on Hot Perfusion of for The Treatment of Malignant Seroperitoneum   【Abstract】 Objective To explore clinical effects of hot perfusion of nedaplatin and oxaliplatin for treatment of malignant seroperitoneum.Methods Ninety two patients with malignant seroperitoneum were randomly divided into two groups with 46 cases in each group. The patients in the control group were subject to the therapy of oxaliplatin hot infusion, while the patients in the observation group was subject to the therapy of nedaplatin hot perfusion, and the treatment efficacy, incurrence of adverse reactions and scores of life quality of patients in two groups were compared.Results The total effective rate of treatment on patients in the observation group was 71.1%, being significantly higher than that of patients in the control group at 45.7%, the incidence of adverse reactions on patients in the observation group hit 17.4%, being lower than that on patients in the control group at 45.7%, and the differences were significant (p<0.05); The scores of life quality of patients after treatment in the observation group was obviously higher than that of patients in the control group, and the difference was significant (p<0.05).Conclusions The therapy of nedaplatin peritoneal effusion delivers affirmative efficacy for the treatment of malignant seroperitoneum, can effectively control the level of hydrops with less adverse reaction and high safety, being of great significance to improve the life quality of patients and being better than that of oxaliplatin hot perfusion treatment.   【Key words】 m

文档评论(0)

sheppha + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:5134022301000003

1亿VIP精品文档

相关文档